Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI110681

Proteolysis by Neutrophils: RELATIVE IMPORTANCE OF CELL-SUBSTRATE CONTACT AND OXIDATIVE INACTIVATION OF PROTEINASE INHIBITORS IN VITRO

Edward J. Campbell, Robert M. Senior, John A. McDonald, David L. Cox, Jeanne M. Greco, and Jill A. Landis

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by Campbell, E. in: JCI | PubMed | Google Scholar

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by Senior, R. in: JCI | PubMed | Google Scholar

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by McDonald, J. in: JCI | PubMed | Google Scholar

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by Cox, D. in: JCI | PubMed | Google Scholar

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by Greco, J. in: JCI | PubMed | Google Scholar

Pulmonary Disease and Respiratory Care Division, Department of Medicine, Washington University at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Find articles by Landis, J. in: JCI | PubMed | Google Scholar

Published October 1, 1982 - More info

Published in Volume 70, Issue 4 on October 1, 1982
J Clin Invest. 1982;70(4):845–852. https://doi.org/10.1172/JCI110681.
© 1982 The American Society for Clinical Investigation
Published October 1, 1982 - Version history
View PDF
Abstract

Polymorphonuclear leukocytes have been implicated in connective tissue injury in a variety of disease processes. To gain insight into mechanisms by which neutrophils might degrade connective tissue macromolecules in the presence of proteinase inhibitors, we have used a model system that allows neutrophils to be held in vitro under physiologic conditions in close proximity to a very proteinase-sensitive substrate, 125I-labeled fibronectin. We have found: (a) neutrophils spread rapidly on the fibronectin substrate; (b) fibronectin proteolysis by neutrophils is largely attributable to released elastase, and is linearly related to cell number over the range of 2,000 to 30,000 cells per assay; (c) oxidants released from neutrophils stimulated by opsonized zymosan or phorbol myristate acetate do not protect released elastase from inhibition by α1-proteinase inhibitor or α2-macroglobulin; (d) neutrophil myeloperoxidase and enzymatically generated superoxide anion render α1-proteinase inhibitor ineffective against fibronectin proteolysis when neutrophils are added 30 min later; and (e) α1-proteinase inhibitor and α2-macroglobulin incompletely inhibit fibronectin proteolysis by neutrophils (79.8±6.3 and 73.5±12.0%, respectively.) The data suggested that proteolysis due to neutrophils that are in contact with susceptible macromolecules may occur due to partial exclusion of inhibitors from the cell-substrate interface. Although confirming that α1-proteinase inhibitor is ineffective against neutrophil-derived proteolysis after exposure to oxidants, these studies did not support the hypothesis that oxidants released from stimulated neutrophils enhance activity of proteinases they release in the presence of α1-proteinase inhibitor. We anticipate that further studies with this test system will be helpful in defining conditions that modulate inflammatory connective tissue injury in diseases such as pulmonary emphysema and rheumatoid arthritis.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 845
page 845
icon of scanned page 846
page 846
icon of scanned page 847
page 847
icon of scanned page 848
page 848
icon of scanned page 849
page 849
icon of scanned page 850
page 850
icon of scanned page 851
page 851
icon of scanned page 852
page 852
Version history
  • Version 1 (October 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts